Thema: US92532F1003
Vertex Pharma, US92532F1003
Vertex Pharma US92532F1003 zeigt die Boston Skyline am Wasser in weicher Aquarell-Malerei-Optik mit Segelbooten - Foto: THN
Vertex Pharma after-hours: EUR 459.58, prior close EUR 448.90
Vertex Pharma traded at EUR 459.58 after-hours at 10:53 p.m. CEST on October 9, 2026, up 2.38 percent at Lang & Schwarz. The Nasdaq Composite was up 0.64 percent.
ad-hoc-news.de, 09.10.26 22:54 Uhr
Vertex Pharma, US92532F1003
Vertex Pharma stock rises to EUR 455.50 P / E 29.7 amid ...
Vertex Pharma stock stood EUR 6.60 above its prior close of EUR 448.90 on October 9, 2026. Its 52-week range is USD 402.58 to USD 560.25.
ad-hoc-news.de, 09.10.26 19:54 Uhr
Vertex Pharma, US92532F1003
RBC raises target for Vertex Pharma stock from USD 570 to ...
Inaxaplin cut UACR 42.70 percent from baseline on September 22, 2026. Vertex Pharma stock costs EUR 458.98 on October 9, 2026 versus EUR 448.90.
ad-hoc-news.de, 09.10.26 16:27 Uhr
Vertex Pharma, US92532F1003
Vertex Pharma after-hours: EUR 448.95 prior close EUR 451.65 ...
At 10:50 p.m. CEST on October 8, Vertex Pharma was at EUR 448.95 in after-hours trading at Lang & Schwarz, down 0.60 percent versus the prior close.
ad-hoc-news.de, 08.10.26 22:52 Uhr
Vertex Pharma, US92532F1003
Vertex Pharma stock stands at EUR 449.93 with USD 128.1 ...
Vertex Pharma stock costs EUR 449.93 on October 8, 2026, versus EUR 451.65. Nasdaq P/E is 29.40.
ad-hoc-news.de, 08.10.26 19:50 Uhr
Vertex Pharma, US92532F1003
Morgan Stanley rates Vertex Pharma stock Buy at USD 665.00 ...
Vertex Pharma stock trades at EUR 447.33 on October 8, 2026, down 0.96 percent. Second-quarter revenue rose 12.50 percent to USD 3.33 billion.
ad-hoc-news.de, 08.10.26 15:46 Uhr
Vertex Pharma, US92532F1003
Vertex Pharma gains 1.55 percent after-hours to EUR 453.03 ...
Vertex Pharma traded at EUR 453.03 after-hours at 8:38 p.m. CEST on October 7, 2026, up plus 1.55 percent versus the prior Lang & Schwarz close.
ad-hoc-news.de, 07.10.26 20:41 Uhr
Vertex Pharma, US92532F1003
Vertex Pharmaceuticals stock gains 1.63 percent on October ...
Vertex Pharmaceuticals stock traded at USD 510.51 by 10:59 a.m. ET on October 7, 2026. Second-quarter revenue reached USD 3.33 billion, up 12.5 percent year over year.
ad-hoc-news.de, 07.10.26 17:00 Uhr
Vertex Pharma, US92532F1003
UBS raises target for Vertex Pharmaceuticals stock to USD ...
Vertex Pharmaceuticals stock costs EUR 452.28 on October 7, 2026 versus EUR 446.10. Second-quarter 2026 revenue rose 12.00 percent to USD 3.33 billion.
ad-hoc-news.de, 07.10.26 14:59 Uhr
Vertex Pharma, US92532F1003
Vertex Pharmaceuticals stock pre-market at EUR 446.85: plus ...
